Managing dyslipidemia in chronic kidney disease: a comprehensive overview of evidence and recommendations.

Korean J Intern Med · 2025 · PMC12611488 · PMID 41223870

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

After a median follow-up of 5.4 years, the fluvastatin group showed a 17% RR reduction in the primary outcome compared to the placebo group; however, this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.